4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000067
EVP, Chief Development Officer sold 4,141 shares at $75.66 ($313,308)
- EVP, Chief Development Officer acquired 11,119 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kordasiewicz Holly B. · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-15 | Exercise or conversion : show line 1 in the form | +11,119 | 18,859 | D | ||
| 2026-01-16 | Sale : show line 2 in the form | −4,141 | $75.66 | $313,308 | 14,718 | D |
| Open-market sales · 4,141 sh · avg $75.66 · $313,308 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-15 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −11,119 | 20,830 | D |
| 2026-01-15 | Grant or award : show line 4 in the form Restricted Stock Unit | +13,650 | 34,480 | D |
| 2026-01-15 | Grant or award : show line 5 in the form Restricted Stock Unit | +11,250 | 45,730 | D |
Loading xslF345X05/edgardoc.xml…